Literature DB >> 16042668

Statin use after acute myocardial infarction: a nationwide study in Denmark.

Jeppe N Rasmussen1, Gunnar H Gislason, Steen Z Abildstrom, Søren Rasmussen, Ida Gustafsson, Pernille Buch, Jens Friberg, Lars Køber, Christian Torp-Pedersen, Mette Madsen, Steen Stender.   

Abstract

AIMS: To study outpatient statin use after first acute myocardial infarction (AMI) in Denmark between 1995 and 2002 and to determine the predictors of statin use.
METHODS: This is a nationwide population-based study using administrative registries. Patients with first AMI between 1995 and 2002 older than 30 years of age and alive 6 months after discharge (n = 45 219) were identified through the National Patient Registry. The statins purchased by these patients within 6 months after discharge were determined using the Registry of Medicinal Product Statistics, a nationwide prescription database.
RESULTS: Statin use following AMI increased from 13% in 1995 to 61% in 2002. In 2002, 81% of patients aged 30-64 years used statins. Older patients used fewer statins, but use increased more among patients aged 75-84 years: from 1.3% to 43%. Use in elderly patients did not differ according to gender in 2000-02, but young men used more than younger women. In 2000-02, patients with diabetes (odds ratio (OR): 0.84; 95% confidence interval (CI): 0.74-0.95) and with heart failure (OR: 0.70; 95% CI: 0.64-0.76) were undertreated; this trend was present throughout the period.
CONCLUSIONS: In this nationwide study, younger patients after AMI had high statin use in 2002, but high-risk patients such as those with diabetes and heart failure were still being undertreated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042668      PMCID: PMC1884927          DOI: 10.1111/j.1365-2125.2005.02408.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  34 in total

1.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

2.  Growth in use of statins after trials is not targeted to most appropriate patients.

Authors:  J Feely; P McGettigan; A Kelly
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

3.  [Prevalence and incidence of dementia in Denmark. The Odense study].

Authors:  K Andersen; A Lolk; H Nielsen; P Kragh-Sørensen
Journal:  Ugeskr Laeger       Date:  2000-08-14

4.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

5.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

Review 6.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

Review 7.  Drug treatment of hyperlipidemia in women.

Authors:  Judith M E Walsh; Michael Pignone
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Authors:  K Pyŏrälä; T R Pedersen; J Kjekshus; O Faergeman; A G Olsson; G Thorgeirsson
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

9.  Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study.

Authors:  L Køber; C Torp-Pedersen
Journal:  Am J Cardiol       Date:  1995-07-01       Impact factor: 2.778

10.  Recall accuracy for prescription medications: self-report compared with database information.

Authors:  S L West; D A Savitz; G Koch; B L Strom; H A Guess; A Hartzema
Journal:  Am J Epidemiol       Date:  1995-11-15       Impact factor: 4.897

View more
  8 in total

1.  Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.

Authors:  M L Norgaard; S S Andersen; T K Schramm; F Folke; C H Jørgensen; M L Hansen; C Andersson; D M Bretler; A Vaag; L Køber; C Torp-Pedersen; G H Gislason
Journal:  Diabetologia       Date:  2010-05-09       Impact factor: 10.122

2.  Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study.

Authors:  Henriette Thisted Horsdal; Anne Vingård Olesen; Christiane Gasse; Henrik Toft Sørensen; Robert C Green; Søren Paaske Johnsen
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

3.  Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.

Authors:  Reimar W Thomsen; Søren P Johnsen; Anne V Olesen; Jens T Mortensen; Henrik Bøggild; Jørn Olsen; Henrik T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.

Authors:  Nele Laleman; Séverine Henrard; Marjan van den Akker; Geert Goderis; Frank Buntinx; Gijs Van Pottelbergh; Bert Vaes
Journal:  BMC Cardiovasc Disord       Date:  2018-11-06       Impact factor: 2.298

5.  Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006.

Authors:  H Dominguez; T K Schramm; M L Norgaard; S Z Abildstrøm; L Kober; C Jørgensen; T J Guterbaum; H E Poulsen; C Torp-Pedersen; G H Gislason
Journal:  Open Cardiovasc Med J       Date:  2009-11-12

Review 6.  Atorvastatin and cardiovascular risk in the elderly--patient considerations.

Authors:  Subroto Acharjee; Francine K Welty
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

7.  Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study.

Authors:  Ingeborg Hartz; Solveig Sakshaug; Kari Furu; Anders Engeland; Anne Elise Eggen; Inger Njølstad; Svetlana Skurtveit
Journal:  BMC Clin Pharmacol       Date:  2007-12-05

8.  Use of recommended medications after myocardial infarction in Austria.

Authors:  Wolfgang C Winkelmayer; Anna E Bucsics; Alexandra Schautzer; Peter Wieninger; Michaela Pogantsch
Journal:  Eur J Epidemiol       Date:  2007-12-07       Impact factor: 8.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.